Medlive Technology Co (HKSE:02192) Days Sales Outstanding : 61.07 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Days Sales Outstanding?

Medlive Technology Co's average Accounts Receivable for the six months ended in Dec. 2024 was HK$112.5 Mil. Medlive Technology Co's Revenue for the six months ended in Dec. 2024 was HK$336.3 Mil. Hence, Medlive Technology Co's Days Sales Outstanding for the six months ended in Dec. 2024 was 61.07.

The historical rank and industry rank for Medlive Technology Co's Days Sales Outstanding or its related term are showing as below:

HKSE:02192' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.9 Med: 91.67 Max: 113.81
Current: 70.2

During the past 7 years, Medlive Technology Co's highest Days Sales Outstanding was 113.81. The lowest was 64.90. And the median was 91.67.

HKSE:02192's Days Sales Outstanding is ranked worse than
71.97% of 660 companies
in the Healthcare Providers & Services industry
Industry Median: 47.245 vs HKSE:02192: 70.20

Medlive Technology Co's Days Sales Outstanding declined from Dec. 2023 (77.07) to Dec. 2024 (61.07).

Medlive Technology Co Days Sales Outstanding Historical Data

The historical data trend for Medlive Technology Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Days Sales Outstanding Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

64.90

75.28

103.81

91.67

80.79

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial							83.72	99.21	77.07	70.15	61.07

Competitive Comparison of Medlive Technology Co's Days Sales Outstanding

For the Health Information Services subindustry, Medlive Technology Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Medlive Technology Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Medlive Technology Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (120.175	+	143.784)	/	2 )	/	596.247	*	365
=	131.9795					/	596.247	*	365
=	80.79

Medlive Technology Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (81.308	+	143.784)	/	2 )	/	336.33	*	365 / 2
=	112.546					/	336.33	*	365 / 2
=	61.07

Medlive Technology Co (HKSE:02192) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Medlive Technology Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that helps with medical conferences and clinical research.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng	2101 Beneficial owner
Liu Lingdi	2101 Beneficial owner
Tian Lixin	2101 Beneficial owner
Tiantian Co., Limited
M3, Inc.	2101 Beneficial owner
Sony Group Corporation	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner

Medlive Technology Co Headlines

No Headlines